Icecure Selling And Marketing Expenses vs Net Interest Income Analysis

ICCM Stock

USD 0.71 0.11 18.33%

Icecure Medical financial indicator trend analysis is infinitely more than just investigating Icecure Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Icecure Medical is a good investment. Please check the relationship between Icecure Medical Selling And Marketing Expenses and its Net Interest Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

Selling And Marketing Expenses vs Net Interest Income

Selling And Marketing Expenses vs Net Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Icecure Medical Selling And Marketing Expenses account and Net Interest Income. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Icecure Medical's Selling And Marketing Expenses and Net Interest Income is 0.91. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Net Interest Income in the same time period over historical financial statements of Icecure Medical, assuming nothing else is changed. The correlation between historical values of Icecure Medical's Selling And Marketing Expenses and Net Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Icecure Medical are associated (or correlated) with its Net Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Interest Income has no effect on the direction of Selling And Marketing Expenses i.e., Icecure Medical's Selling And Marketing Expenses and Net Interest Income go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Selling And Marketing Expenses

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Most indicators from Icecure Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Icecure Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.As of the 24th of November 2024, Sales General And Administrative To Revenue is likely to grow to 1.56, while Selling General Administrative is likely to drop about 2.4 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	11.9M	18.2M	16.9M	17.7M
Cost Of Revenue	1.9M	1.6M	1.9M	1.1M

Total Operating Expenses Cost Of Revenue

Icecure Medical fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Other Liab	Net Tangible Assets	Current Deferred Revenue	Net Invested Capital
Common Stock Shares Outstanding		0.74	0.77	0.79	0.7	0.97	-0.7	-0.99	0.74	0.68	0.96	0.28	0.69	0.71	-0.14	0.86	0.27	0.9	0.72	0.73	0.94	-0.48	-0.5	0.89	0.52	0.78
Total Assets	0.74		0.7	0.81	0.99	0.8	-0.98	-0.7	0.88	0.98	0.84	0.66	0.99	0.85	0.13	0.92	0.32	0.89	0.76	1.0	0.75	-0.2	-0.48	0.88	0.5	0.94
Other Current Liab	0.77	0.7		0.89	0.63	0.75	-0.57	-0.84	0.78	0.58	0.75	0.22	0.59	0.74	0.26	0.84	0.62	0.89	0.86	0.69	0.85	-0.44	-0.07	0.82	0.37	0.73
Total Current Liabilities	0.79	0.81	0.89		0.73	0.76	-0.72	-0.83	0.9	0.72	0.77	0.37	0.73	0.87	0.35	0.87	0.51	0.89	0.98	0.8	0.91	-0.58	-0.1	0.89	0.66	0.85
Total Stockholder Equity	0.7	0.99	0.63	0.73		0.78	-0.99	-0.65	0.83	0.99	0.82	0.67	0.99	0.79	0.05	0.9	0.24	0.85	0.67	0.99	0.68	-0.11	-0.56	0.83	0.44	0.9
Property Plant And Equipment Net	0.97	0.8	0.75	0.76	0.78		-0.78	-0.94	0.72	0.76	1.0	0.37	0.77	0.73	-0.18	0.88	0.24	0.89	0.68	0.79	0.87	-0.31	-0.6	0.87	0.39	0.78
Net Debt	-0.7	-0.98	-0.57	-0.72	-0.99	-0.78		0.64	-0.82	-1.0	-0.81	-0.68	-1.0	-0.79	-0.02	-0.87	-0.18	-0.82	-0.65	-0.98	-0.67	0.13	0.58	-0.81	-0.48	-0.9
Retained Earnings	-0.99	-0.7	-0.84	-0.83	-0.65	-0.94	0.64		-0.74	-0.63	-0.92	-0.2	-0.63	-0.72	0.08	-0.85	-0.32	-0.9	-0.76	-0.69	-0.95	0.54	0.39	-0.89	-0.53	-0.76
Accounts Payable	0.74	0.88	0.78	0.9	0.83	0.72	-0.82	-0.74		0.82	0.74	0.58	0.82	0.8	0.42	0.85	0.59	0.85	0.91	0.88	0.88	-0.56	-0.13	0.92	0.74	0.97
Cash	0.68	0.98	0.58	0.72	0.99	0.76	-1.0	-0.63	0.82		0.79	0.68	1.0	0.8	0.04	0.87	0.18	0.82	0.66	0.99	0.66	-0.12	-0.57	0.81	0.48	0.9
Non Current Assets Total	0.96	0.84	0.75	0.77	0.82	1.0	-0.81	-0.92	0.74	0.79		0.44	0.8	0.76	-0.14	0.88	0.25	0.9	0.7	0.82	0.87	-0.28	-0.61	0.88	0.4	0.81
Non Currrent Assets Other	0.28	0.66	0.22	0.37	0.67	0.37	-0.68	-0.2	0.58	0.68	0.44		0.68	0.6	0.35	0.37	0.22	0.38	0.41	0.67	0.34	0.19	-0.36	0.46	0.23	0.59
Cash And Short Term Investments	0.69	0.99	0.59	0.73	0.99	0.77	-1.0	-0.63	0.82	1.0	0.8	0.68		0.8	0.03	0.88	0.18	0.83	0.66	0.99	0.67	-0.12	-0.57	0.82	0.48	0.9
Net Receivables	0.71	0.85	0.74	0.87	0.79	0.73	-0.79	-0.72	0.8	0.8	0.76	0.6	0.8		0.32	0.77	0.39	0.81	0.86	0.85	0.79	-0.24	-0.25	0.76	0.42	0.79
Non Current Liabilities Total	-0.14	0.13	0.26	0.35	0.05	-0.18	-0.02	0.08	0.42	0.04	-0.14	0.35	0.03	0.32		0.0	0.77	0.03	0.51	0.14	0.19	-0.31	0.72	0.12	0.25	0.25
Inventory	0.86	0.92	0.84	0.87	0.9	0.88	-0.87	-0.85	0.85	0.87	0.88	0.37	0.88	0.77	0.0		0.33	0.98	0.78	0.91	0.84	-0.36	-0.45	0.94	0.52	0.88
Other Current Assets	0.27	0.32	0.62	0.51	0.24	0.24	-0.18	-0.32	0.59	0.18	0.25	0.22	0.18	0.39	0.77	0.33		0.36	0.63	0.32	0.51	-0.44	0.52	0.41	0.21	0.48
Other Stockholder Equity	0.9	0.89	0.89	0.89	0.85	0.89	-0.82	-0.9	0.85	0.82	0.9	0.38	0.83	0.81	0.03	0.98	0.36		0.81	0.87	0.89	-0.39	-0.42	0.96	0.52	0.86
Total Liab	0.72	0.76	0.86	0.98	0.67	0.68	-0.65	-0.76	0.91	0.66	0.7	0.41	0.66	0.86	0.51	0.78	0.63	0.81		0.75	0.88	-0.61	0.05	0.83	0.65	0.83
Total Current Assets	0.73	1.0	0.69	0.8	0.99	0.79	-0.98	-0.69	0.88	0.99	0.82	0.67	0.99	0.85	0.14	0.91	0.32	0.87	0.75		0.74	-0.2	-0.47	0.86	0.5	0.94
Common Stock	0.94	0.75	0.85	0.91	0.68	0.87	-0.67	-0.95	0.88	0.66	0.87	0.34	0.67	0.79	0.19	0.84	0.51	0.89	0.88	0.74		-0.66	-0.21	0.93	0.67	0.86
Short Long Term Debt Total	-0.48	-0.2	-0.44	-0.58	-0.11	-0.31	0.13	0.54	-0.56	-0.12	-0.28	0.19	-0.12	-0.24	-0.31	-0.36	-0.44	-0.39	-0.61	-0.2	-0.66		-0.34	-0.52	-0.83	-0.48
Other Liab	-0.5	-0.48	-0.07	-0.1	-0.56	-0.6	0.58	0.39	-0.13	-0.57	-0.61	-0.36	-0.57	-0.25	0.72	-0.45	0.52	-0.42	0.05	-0.47	-0.21	-0.34		-0.36	0.01	-0.3
Net Tangible Assets	0.89	0.88	0.82	0.89	0.83	0.87	-0.81	-0.89	0.92	0.81	0.88	0.46	0.82	0.76	0.12	0.94	0.41	0.96	0.83	0.86	0.93	-0.52	-0.36		0.68	0.91
Current Deferred Revenue	0.52	0.5	0.37	0.66	0.44	0.39	-0.48	-0.53	0.74	0.48	0.4	0.23	0.48	0.42	0.25	0.52	0.21	0.52	0.65	0.5	0.67	-0.83	0.01	0.68		0.69
Net Invested Capital	0.78	0.94	0.73	0.85	0.9	0.78	-0.9	-0.76	0.97	0.9	0.81	0.59	0.9	0.79	0.25	0.88	0.48	0.86	0.83	0.94	0.86	-0.48	-0.3	0.91	0.69

Click cells to compare fundamentals

Icecure Medical Account Relationship Matchups

Icecure Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	13.6M	17.1M	28.5M	37.0M	45.6M	47.9M
Total Assets	7.3M	10.3M	32.3M	30.2M	16.4M	12.7M
Other Current Liab	1.1M	3.1M	2.0M	2.8M	3.0M	1.8M
Total Current Liabilities	3.6M	3.9M	4.0M	4.3M	3.9M	2.7M
Total Stockholder Equity	2.6M	4.6M	27.0M	25.4M	12.2M	9.1M
Property Plant And Equipment Net	377.4K	621.7K	1.6M	2.0M	2.2M	2.3M
Net Debt	(5.5M)	(3.2M)	(24.7M)	(23.1M)	(9.9M)	(10.4M)
Retained Earnings	(48.5M)	(57.0M)	(58.4M)	(75.4M)	(90.1M)	(85.6M)
Accounts Payable	425.7K	645K	881K	714K	502K	452.6K
Cash	5.8M	3.5M	25.6M	23.7M	10.5M	9.3M
Non Current Assets Total	417.6K	658.4K	2.0M	2.1M	2.2M	2.3M
Non Currrent Assets Other	19.9K	36.7K	333K	34K	39.1K	67.8K
Cash And Short Term Investments	5.8M	3.5M	25.6M	23.7M	11.1M	9.4M
Net Receivables	104.8K	165K	771K	366K	103K	108.2K
Liabilities And Stockholders Equity	7.3M	10.3M	32.3M	30.2M	16.4M	12.7M
Non Current Liabilities Total	1.1M	1.8M	1.3M	430K	376K	357.2K
Inventory	717.3K	1.1M	2.0M	2.9M	2.3M	1.2M
Other Current Assets	301.1K	5.0M	2.0M	1.2M	965K	1.4M
Other Stockholder Equity	45.4M	62.6M	85.4M	100.8M	102.2M	62.7M
Total Liab	4.7M	5.8M	5.3M	4.8M	4.2M	3.6M
Total Current Assets	6.9M	9.7M	30.3M	28.1M	14.2M	11.8M
Common Stock	1.3M	2.7M	3.5M	5.0M	5.8M	6.1M
Other Assets	139K	118K	333K	34K	39.1K	37.1K
Other Liab	2.7M	3.3M	5.7M	618K	556.2K	528.4K
Net Tangible Assets	9.1M	14.7M	27.0M	25.4M	29.2M	16.1M
Net Invested Capital	9.1M	14.7M	27.0M	25.4M	12.2M	16.3M
Non Current Liabilities Other	2.7M	2.1M	759K	618K	556.2K	528.4K
Net Working Capital	11.3M	18.6M	26.3M	23.8M	10.3M	16.7M
Property Plant Equipment	1.3M	2.0M	1.6M	2.0M	2.3M	1.4M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:

How To Invest In Icecure

Details

Is Icecure Stock a good investment?

Details

What is Icecure Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.29)

Revenue Per Share

0.071

Quarterly Revenue Growth

0.079

Return On Assets

(0.47)

Return On Equity

(0.94)

The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Icecure Selling And Marketing Expenses vs Net Interest Income Analysis

Selling And Marketing Expenses vs Net Interest Income

Selling And Marketing Expenses vs Net Interest Income Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Net Interest Income

Icecure Medical fundamental ratios Correlations

Icecure Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Icecure Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Cash	+ 0.99	Total Stockholder Equity

Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Retained Earnings	- 0.99	Common Stock Shares Outstanding
Total Current Assets	- 0.98	Net Debt
Net Debt	- 0.98	Total Assets